Moderna
MRNA
#1391
Rank
โ‚ฌ12.45 B
Marketcap
32,36ย โ‚ฌ
Share price
-3.92%
Change (1 day)
-65.20%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ1.82 M-98.83%
2024โ‚ฌ0.15 B15.08%
2023โ‚ฌ0.13 B-50.15%
2022โ‚ฌ0.27 B-85.7%
2021โ‚ฌ1.90 B158.2%
2020โ‚ฌ0.73 B369.18%
2019โ‚ฌ0.15 B1011.49%
2018โ‚ฌ14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ0.77 Mโ‚ฌ6.63 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ76.76 Mโ‚ฌ0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.09 Mโ‚ฌ0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.46 Mโ‚ฌ45.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.23 Mโ‚ฌ0.14 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ0.55 Mโ‚ฌ8.17 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ21.76 Mโ‚ฌ0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA